(Q38758615)

6 September 2017

A New Role for an Old Drug: Metformin Targets MicroRNAs in Treating Diabetes and Cancer (English)

1 reference

6 September 2017

1 reference

1 reference

Joseph Yi Zhou

1

1 reference

PubMed ID

26936407

6 September 2017

Biao Xu

series ordinal

2

1 reference

PubMed ID

26936407

6 September 2017

Lixin Li

series ordinal

3

1 reference

6 September 2017

1 September 2015

1 reference

Drug Development Research

6 September 2017

1 reference

6 September 2017

76

1 reference

6 September 2017

6

1 reference

6 September 2017

263-269

1 reference

Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF

6 September 2017

1 reference

Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro

21 January 2018

1 reference

Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression

21 January 2018

1 reference

Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.

21 January 2018

1 reference

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC.

21 January 2018

1 reference

21 January 2018

1 reference

Circulating microRNAs and aerobic fitness--the HUNT-Study

21 January 2018

1 reference

Origins and Mechanisms of miRNAs and siRNAs

21 January 2018

1 reference

MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer

21 January 2018

1 reference

Elevation of miR-221 and -222 in the internal mammary arteries of diabetic subjects and normalization with metformin

21 January 2018

1 reference

Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype

21 January 2018

1 reference

Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development

21 January 2018

1 reference

Metformin and reduced risk of cancer in diabetic patients

21 January 2018

1 reference

Diabetes, cancer, and metformin: connections of metabolism and cell proliferation

21 January 2018

1 reference

MicroRNAs: 'ribo-regulators' of glucose homeostasis

21 January 2018

1 reference

Reduced miR-31 and let-7 maintain the balance between differentiation and quiescence in lung cancer stem-like side population cells

21 January 2018

1 reference

A mirror of two faces: Lin28 as a master regulator of both miRNA and mRNA.

21 January 2018

1 reference

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

21 January 2018

1 reference

Impact of miR-155 and miR-126 as novel biomarkers on the assessment of disease progression and prognosis in adult T-cell leukemia.

21 January 2018

1 reference

Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells

21 January 2018

1 reference

The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo

21 January 2018

1 reference

Pathogenic and therapeutic role of miRNAs in breast cancer

21 January 2018

1 reference

Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells

21 January 2018

1 reference

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

21 January 2018

1 reference

Metformin induces unique biological and molecular responses in triple negative breast cancer cells

21 January 2018

1 reference

Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application

21 January 2018

1 reference

A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia

21 January 2018

1 reference

MiR-206, a key modulator of skeletal muscle development and disease.

21 January 2018

1 reference

Metformin may antagonize Lin28 and/or Lin28B activity, thereby boosting let-7 levels and antagonizing cancer progression.

21 January 2018

1 reference

Metformin: a potential therapeutic agent for recurrent colon cancer

21 January 2018

1 reference

Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: induction of the tumor suppressor miRNA let-7a and suppression of the TGFβ-induced oncomiR miRNA-181a

21 January 2018

1 reference

Targeting the circulating microRNA signature of obesity.

21 January 2018

1 reference

Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization.

21 January 2018

1 reference

MicroRNAs and prostate cancer

21 January 2018

1 reference

A pancreatic islet-specific microRNA regulates insulin secretion

21 January 2018

1 reference

MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications

21 January 2018

1 reference

Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection

21 January 2018

1 reference

microRNAs in breast cancer development and treatment.

21 January 2018

1 reference

Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer

21 January 2018

1 reference

MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression

21 January 2018

1 reference

Early detection of colorectal cancer: from conventional methods to novel biomarkers

21 January 2018

1 reference

Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b

21 January 2018

1 reference

Metformin inhibits lung cancer cells proliferation through repressing microRNA-222.

21 January 2018

1 reference

MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells.

21 January 2018

1 reference

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Farooki and Schneider

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

MicroRNAs are key regulators of brown adipogenesis

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/DDR.21265

1 reference

6 September 2017

1 reference

PubMed ID

26936407